At this time, participants must be at least 13 years old to enroll in the VISTA trial. However, the sponsor is currently running a prescreening program open to younger patients. If they participate and are found to be a potential candidate for laru-zova clinical trials, they could be considered for the trial once they meet age eligibility. NOTE: Participating in the prescreening program is no cost to patients and families and does not guarantee enrollment in the laru-zova clinical trials.
If you would like to move forward with the prescreen program, please enter your contact information below and a member of the laru-zova clinical trials team will contact you.